Respiratory nitric oxide levels in experimental human influenza

Chest

Volumn 114, Issue 2, 1998, Pages 452-456

  Murphy, Andrew W ^a   Platts Mills, Thomas A E ^a   Lobo, Monica ^a   Hayden, Frederick ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Influenza A; Nitric oxide; Upper respiratory tract infection

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INFLUENZA; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SYMPTOMATOLOGY; VIRUS DETECTION;

EID: 0031866139     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.2.452     Document Type: Article

References (18)

1. Aston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-51
2. Gustfsson LE, Leone AM, Persson MG, et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. BBRC 1991; 181:852-57
3. Persson MG, Zetterstrom O, Agrenius V, et al. Single-breath nitirc oxide measurements in asthmatic patients and smokers. Lancet 1994; 343:146-47
4. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-70
5. Massaro AF, Gaston B, Kita D, et al. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995; 152:800-03
6. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-35
7. Yates DH, Kharitonov SA, Robbins RA, et al. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152:892-96
8. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454-57
9. Martin U, Bryden K, Devoy M, et al. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunul 1996; 97:768-72
10. Massaro AF, Mehta S, Lilly CM, et al. Elevated nitric oxide concentrations in the isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996; 153:1510-14
11. Robbins RA, Floreani AA, Von Essen SG, et al. Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 1996; 153:1631-35
12. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in the exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995; 8:295-97
13. Nain M, Hinder F, Gong J, et al. Tumor necrosis factor-α production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharide. J Immunol 1990; 145:1921-28
14. Tomoda T, Morita H, Kurashige T, et al. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ producation and local IgA response. Vaccine 1995; 13:185-90
15. Roberts N, Prill A, Mann T. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenzas virus or respiratory syncytial virus. J Exp Med 1986; 163:511-19
16. Peper R, Campen H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microbial Pathogenesis 1995; 19:175-83
17. Hayden FG, Fritz RS, Lobo MC, et al. Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest 1998; 101:643-49
18. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements recommendations: the European Respiratory Society Task Force. Eur Respir J 1997; 10:1483-88